GlassScriptPhysician profile
John W Hsu
NPI 1043439748
$6,374.44
in general payments reported to CMS, 2019-2025
15 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.44 · 2021: $134 · 2022: $124 · 2023: $233 · 2024: $5,550 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,789 · Food and Beverage: $1,736 · Education: $1,500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,789.15 |
| Food and Beverage | $1,736.14 |
| Education | $1,500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,273.77 | 2021-2024 | |
| Smith+Nephew, INC. | $223.89 | 2022-2025 | Grafix Pl, Oasis, Grafix |
| Integra Lifesciences Corporation | $199.42 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $131.59 | 2022-2025 | Endo Gia Ultra, Parietene Ds, Venaseal |
| Tela Bio, INC. | $131.58 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $99.31 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bard Peripheral Vascular, INC. | $82.44 | 2019 | |
| Lemaitre Vascular, INC. | $47.53 | 2022-2024 | Artegraft Vascular Graft |
| Ethicon US, LLC | $34.36 | 2025 | Surgicel Nu-Knit, Evarrest, Vistaseal |
| Boston Scientific Corporation | $30.66 | 2022 | |
| Bioventus LLC | $26.86 | 2023 | |
| Misonix INC | $24.40 | 2021 | |
| 180 Medical, INC. | $24.17 | 2024 | Jobst Relief |
| Penumbra, INC. | $23.20 | 2025 | Pod |
| Davol INC. | $21.26 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.